Squaric acid dibutyl ester by Squarex Pharmaceutical for Herpes Labialis (Oral Herpes): Likelihood of Approval

Squaric acid dibutyl ester is under clinical development by Squarex Pharmaceutical and currently in Phase I for Herpes Labialis (Oral Herpes).

Change Healthcare cyberattack drives 2024 into another record year for health data breaches

As many as 172 million individuals — more than half the population of the United States — may have been impacted by large health data

December 5, 2024

Study warns of high Medicare costs for semaglutide even with restrictive CVD definition

If Medicare Part D narrowly defines cardiovascular disease, the majority of patients would remain ineligible while new federal spending could still exceed $10 billion

August 27, 2024

KFF Health News’ ‘What the Health?’: Live from Austin, examining health equity

The term “health equity” means different things to different people. It’s about access to medical care — but not only access to medical care.

September 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.